UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
EndowmentPosition in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1019231
AUSTIN, TX
Position in VRTX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$42,421
-$648 QoQ
Shares Held
95
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO holds $10,047,771 across 8 Biotechnology names. VRTX ranks #8 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMTX |
Immatics N.V.
|
697,431 | $6,862,721 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
15,692 | $1,165,287 | |
| 3 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
27,376 | $677,829 | |
| 4 | RNTX |
Rein Therapeutics, Inc.
|
511,610 | $665,093 | |
| 5 | ANRO |
Alto Neuroscience, Inc.
|
22,175 | $498,494 | |
| 6 | MRNA |
Moderna, Inc.
|
1,579 | $80,213 | |
| 7 | LXRX |
Lexicon Pharmaceuticals, Inc.
|
35,714 | $55,713 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
95 | $42,421 |
All Filings in VRTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $42,421 | 95 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $43,069 | 95 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $63,837 | 163 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $42,294 | 95 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $46,057 | 95 | Shares | Sole | 2025-05-07 | |
| 2024-03-31 | $78,585 | 188 | Shares | Sole | 2024-08-29 | |
| 2023-12-31 | $76,495 | 188 | Shares | Sole | 2024-08-29 | |
| No filing history on record for this holder in this stock. | ||||||